These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36645024)

  • 1. Keratinocytes activated by IL-4/IL-13 express IL-2Rγ with consequences on epidermal barrier function.
    Progneaux A; Evrard C; De Glas V; Fontaine A; Dotreppe C; De Vuyst E; Nikkels AF; García-González V; Dumoutier L; Lambert de Rouvroit C; Poumay Y
    Exp Dermatol; 2023 May; 32(5):660-670. PubMed ID: 36645024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of interleukin-13 receptor alpha1 on human keratinocytes in the skin of psoriasis and atopic dermatitis.
    Wongpiyabovorn J; Suto H; Ushio H; Izuhara K; Mitsuishi K; Ikeda S; Nakao A; Okumura K; Ogawa H
    J Dermatol Sci; 2003 Oct; 33(1):31-40. PubMed ID: 14527737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scratching Counteracts IL-13 Signaling by Upregulating the Decoy Receptor IL-13Rα2 in Keratinocytes.
    Ulzii D; Kido-Nakahara M; Nakahara T; Tsuji G; Furue K; Hashimoto-Hachiya A; Furue M
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of the IL-13 receptor alpha2-chain by IL-4 and IL-13 in human keratinocytes: involvement of STAT6, ERK and p38 MAPK pathways.
    David M; Ford D; Bertoglio J; Maizel AL; Pierre J
    Oncogene; 2001 Oct; 20(46):6660-8. PubMed ID: 11709700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methyl-β-cyclodextrin treatment combined to incubation with interleukin-4 reproduces major features of atopic dermatitis in a 3D-culture model.
    do Nascimento Pedrosa T; De Vuyst E; Mound A; Lambert de Rouvroit C; Maria-Engler SS; Poumay Y
    Arch Dermatol Res; 2017 Jan; 309(1):63-69. PubMed ID: 27833999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-143 inhibits IL-13-induced dysregulation of the epidermal barrier-related proteins in skin keratinocytes via targeting to IL-13Rα1.
    Zeng YP; Nguyen GH; Jin HZ
    Mol Cell Biochem; 2016 May; 416(1-2):63-70. PubMed ID: 27048505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Interleukin-13 Receptor-α1 Chain Is Essential for Induction of the Alternative Macrophage Activation Pathway by IL-13 but Not IL-4.
    Sheikh F; Dickensheets H; Pedras-Vasconcelos J; Ramalingam T; Helming L; Gordon S; Donnelly RP
    J Innate Immun; 2015; 7(5):494-505. PubMed ID: 25766112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Expression and Regulation of Interleukin-33 in Human Epidermal Keratinocytes: A New Mediator of Atopic Dermatitis and Its Possible Signaling Pathway.
    Du HY; Fu HY; Li DN; Qiao Y; Wang QW; Liu W
    J Interferon Cytokine Res; 2016 Sep; 36(9):552-62. PubMed ID: 27348082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keratinocyte-derived anosmin-1, an extracellular glycoprotein encoded by the X-linked Kallmann syndrome gene, is involved in modulation of epidermal nerve density in atopic dermatitis.
    Tengara S; Tominaga M; Kamo A; Taneda K; Negi O; Ogawa H; Takamori K
    J Dermatol Sci; 2010 Apr; 58(1):64-71. PubMed ID: 20219326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling atopic dermatitis during the morphogenetic process involved in reconstruction of a human epidermis.
    De Vuyst É; Mound A; Lambert de Rouvroit C; Poumay Y
    Curr Res Transl Med; 2016; 64(4):179-183. PubMed ID: 27939456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 helper T-cell cytokines induce morphologic and molecular characteristics of atopic dermatitis in human skin equivalent.
    Kamsteeg M; Bergers M; de Boer R; Zeeuwen PL; Hato SV; Schalkwijk J; Tjabringa GS
    Am J Pathol; 2011 May; 178(5):2091-9. PubMed ID: 21514424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid 1 receptors in keratinocytes attenuate fluorescein isothiocyanate-induced mouse atopic-like dermatitis.
    Gaffal E; Glodde N; Jakobs M; Bald T; Tüting T
    Exp Dermatol; 2014 Jun; 23(6):401-6. PubMed ID: 24750433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The IL-13/periostin/IL-24 pathway causes epidermal barrier dysfunction in allergic skin inflammation.
    Mitamura Y; Nunomura S; Nanri Y; Ogawa M; Yoshihara T; Masuoka M; Tsuji G; Nakahara T; Hashimoto-Hachiya A; Conway SJ; Furue M; Izuhara K
    Allergy; 2018 Sep; 73(9):1881-1891. PubMed ID: 29528494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective role of Galectin-7 for skin barrier impairment in atopic dermatitis.
    Umayahara T; Shimauchi T; Iwasaki M; Sakabe JI; Aoshima M; Nakazawa S; Yatagai T; Yamaguchi H; Phadungsaksawasdi P; Kurihara K; Tokura Y
    Clin Exp Allergy; 2020 Aug; 50(8):922-931. PubMed ID: 32474952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental and Clinical Evidence Suggests That Treatment with Betacellulin Can Alleviate Th2-Type Cytokine-Mediated Impairment of Skin Barrier Function.
    Peng G; Tsukamoto S; Umehara Y; Kishi R; Tominaga M; Takamori K; Okumura K; Ogawa H; Ikeda S; Niyonsaba F
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-4 up-regulation of epidermal interleukin-19 expression in keratinocytes involves the binding of signal transducer and activator of transcription 6 (Stat6) to the imperfect Stat6 sites.
    Bao L; Alexander JB; Shi VY; Mohan GC; Chan LS
    Immunology; 2014 Dec; 143(4):601-8. PubMed ID: 24943510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Interleukin-4 and Interleukin-13 Induced Atopic Dermatitis Human Skin Equivalent Model by a Skin-On-A-Chip.
    Kim K; Kim H; Sung GY
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of cell signaling in a reconstructed human epidermis exposed to sensitizers: IL-8 synthesis and release depend on EGFR activation.
    Frankart A; Coquette A; Schroeder KR; Poumay Y
    Arch Dermatol Res; 2012 May; 304(4):289-303. PubMed ID: 22271211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling.
    Amano W; Nakajima S; Kunugi H; Numata Y; Kitoh A; Egawa G; Dainichi T; Honda T; Otsuka A; Kimoto Y; Yamamoto Y; Tanimoto A; Matsushita M; Miyachi Y; Kabashima K
    J Allergy Clin Immunol; 2015 Sep; 136(3):667-677.e7. PubMed ID: 26115905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Igalan from Inula helenium (L.) suppresses the atopic dermatitis-like response in stimulated HaCaT keratinocytes via JAK/STAT3 signaling.
    Dao TTP; Song K; Kim JY; Kim YS
    Inflamm Res; 2020 Mar; 69(3):309-319. PubMed ID: 32002586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.